DexCom earnings on deck: Margin gains in focus amid sensor shift By Investing.com

DexCom (DXCM) is set to report its second-quarter earnings, with analysts focusing on margin expansion as the company transitions customers to its new G7 15-day sensor. Investors will also be watching the pace of G6 to G7 conversions and updates on Medicare coverage expansion for Type 2 non-insulin using diabetics, a significant long-term growth opportunity. The company is expected to report earnings of $0.61 per share on revenue of $1.29 billion.